An injection containing the antiretroviral drug lenacapavir is highly effective at preventing HIV infection for six months per shot. This is according to top-line study findings announced last week by the pharmaceutical company Gilead. Detailed study findings have not yet been presented at a major scientific conference or published in a reputable scientific journal. To get more details about the effectiveness of this injection, I am joined on the line by…



GUEST: Professor Linda-Gail Bekker, Chief Executive Officer at Desmond Tutu Health Foundation

An injection containing the antiretroviral drug lenacapavir is highly effective at preventing HIV infection for six months per shot. This is according to top-line study findings announced last week by the pharmaceutical company Gilead. Detailed study findings have not yet been presented at a major scientific conference or published in a reputable scientific journal. To get more details about the effectiveness of this injection, I am joined on the line by…
 
GUEST: Professor Linda-Gail Bekker, Chief Executive Officer at Desmond Tutu Health Foundation

Latest News, Trends, and light features for an afternoon commute- Business, Traffic, Weather and Sport

Advertisement